Belgium· BE-AMP-SAM665633-00

Cesora 10 mg/g

A ivermectin product containing ivermectin, registered in Belgium by Laboratoires Medgen. The same ATC class is registered in 14 of our 19 countries.

ATC D11AX22

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedCesora 10 mg/gATCD11AX22REGISTER NO.BE-AMP-SAM665633-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Ivermectin is registered in 14 of 19 countries.

Countries holding a registration under ATC D11AX22 (ivermectin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Ivermectin · ATC D11AX22

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ivermectin
Manufacturer
Laboratoires Medgen
Country
Belgium (BE)
ATC code
D11AX22
ATC class
Ivermectin
Defined daily dose
10 mg, T
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for ivermectin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ivermectin · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • EchinaceaD03AH02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ivermectin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ivermectin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Ivergelan, Ivermectin Stada
  • Bulgaria · Ивермектин, Скабал
  • Cyprus · Scaball, Soolantra
  • Czechia · Ivermektin Aristo, Loutol
  • Germany · Driponin, Iveraxiro
  • Denmark · Ivermectin Medical Valley, Ivermectin Newbury
  • Estonia · Ivermectin Orion, Soolantra
  • Spain · Ivercare, Ivergalen
  • Finland · Ivermectin Glenmark, Ivermectin Medical Valley
  • France · Bibovel, Cesora
  • United Kingdom (Northern Ireland) · Ivermectin, Ivermectin Aristo
  • Greece · Scaball, Soolantra
  • Hungary · Soolantra
  • Ireland · Iverscab, Soolantra
  • Iceland · Ivermcetin Stada, Ivermectin Medical Valley
  • Italy · Efacti, Ivercare
  • Lithuania · Ivermectin Orion, Soolantra
  • Luxembourg · Ivermectin Eg, Ivermectin Substipharm
  • Latvia · Ivermectin Orion, Ivermectine Orion
  • Malta · Soolantra
  • Netherlands · Ivergalen, Ivermectin Substipharm
  • Norway · Ivermectin Glenmark, Ivermectin Medical Valley
  • Poland · Ivermectin Medical Valley, Ivermectin Orion
  • Portugal · Ivergalen, Ivermectina Cantabria
  • Romania · Soolantra
  • Sweden · Cesora, Efrinter
  • Slovakia · Ivermectin Exeltis, Soolantra

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e4e88428-59a9-46c8-81ed-2f6d46e69f8d
GET /v1/drugs/e4e88428-59a9-46c8-81ed-2f6d46e69f8d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Cream",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Cesora 10 mg/g",
  "name_fr": "Cesora 10 mg/g",
  "name_nl": "Cesora 10 mg/g",
  "amp_code": "SAM665633-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "35.0000",
    "0.5500",
    "40.0000",
    "2.0000",
    "1.0000",
    "20.0000",
    "0.8000",
    "25.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Ivermectin",
    "Cetyl Alcohol",
    "Disodium Edetate",
    "Glycerol 85%",
    "Methyl Parahydroxybenzoate",
    "Propyl Parahydroxybenzoate",
    "Propylene Glycol",
    "Sodium Hydroxide",
    "Stearyl Alcohol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ivermectin",
  "authorisation_numbers": [
    "BE665633"
  ]
}

See everything about ivermectin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.